# Foresite Capital's Pharma Investments: 12 Startups in Its Portfolio (2026) > The 12 Pharma startups Foresite Capital has backed, by stage: $2.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/forsite-capital-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 5 - [Vaxcyte](https://millionrounds.com/company/vaxcyte) - [Cullinan Therapeutics](https://millionrounds.com/company/cullinan-therapeutics) - [GH Research](https://millionrounds.com/company/gh-research) - [ImageneBio](https://millionrounds.com/company/imagenebio) - [ALX Oncology](https://millionrounds.com/company/alx-oncology) ## Series B 5 - [Evonetix](https://millionrounds.com/company/evonetix) - [Seaport Therapeutics](https://millionrounds.com/company/seaport-therapeutics) - [Pinnacle Medicines](https://millionrounds.com/company/pinnacle-medicines) - [Aeovian Pharmaceuticals](https://millionrounds.com/company/aeovian-pharmaceuticals) - [Pleno](https://millionrounds.com/company/pleno) ## Series C and later 2 - [ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals) - [Genomics](https://millionrounds.com/company/genomics) ## Segment by segment ### Stage not reported 5 startups · $1.2B raised - [**Vaxcyte**](https://millionrounds.com/company/vaxcyte) Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. United States $633M - [**Cullinan Therapeutics**](https://millionrounds.com/company/cullinan-therapeutics) Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly. United States $280M - [**GH Research**](https://millionrounds.com/company/gh-research) GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness. Ireland $268M - [**ImageneBio**](https://millionrounds.com/company/imagenebio) ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases United States $30M - [**ALX Oncology**](https://millionrounds.com/company/alx-oncology) ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. United States $10M ### Series B 5 startups · $686M raised - [**Evonetix**](https://millionrounds.com/company/evonetix) Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale. United Kingdom $276M - [**Seaport Therapeutics**](https://millionrounds.com/company/seaport-therapeutics) Seaport Therapeutics operates as a clinical stage biopharmaceutical company. United States $240M - [**Pinnacle Medicines**](https://millionrounds.com/company/pinnacle-medicines) Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs. United States $90M - [**Aeovian Pharmaceuticals**](https://millionrounds.com/company/aeovian-pharmaceuticals) Aeovian Pharmaceuticals, Inc. United States $55M - [**Pleno**](https://millionrounds.com/company/pleno) SAAS for Carbon Project Developers United States $25M ### Series C and later 2 startups · $341M raised - [**ORIC Pharmaceuticals**](https://millionrounds.com/company/oric-pharmaceuticals) ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance. United States $248M - [**Genomics**](https://millionrounds.com/company/genomics) Genomics Ltd, founded in 2014 in Oxford, UK, is a global techbio and precision medicine company. United Kingdom $93M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names Foresite Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Foresite Capital's Biotech portfolio** 68 startups · $13B](https://millionrounds.com/portfolio-maps/forsite-capital-biotech-portfolio)[Sector portfolio **Foresite Capital's Healthtech portfolio** 10 startups · $973M](https://millionrounds.com/portfolio-maps/forsite-capital-healthtech-portfolio)[Portfolio map **Foresite Capital portfolio map** 91 startups · $17B](https://millionrounds.com/portfolio-maps/forsite-capital-portfolio-map)[Co-investors **Who invests with Foresite Capital** 77 co-investors](https://millionrounds.com/portfolio-maps/forsite-capital-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio) ## Raising from investors like Foresite Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)